Assessing methods to quantitatively validate TGFβ-dependent autophagy.

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Transforming growth factor beta (TGFβ) is implicated in tumorigenesis by inhibiting immune surveillance and promoting epithelial-mesenchymal transition (EMT).
• TGFβ may enhance tumor progression by activating autophagy, conferring chemoresistance and promoting invasive, anti-apoptotic properties in cancer cells.

Purpose of the Study:

• To investigate how TGFβ1 influences autophagy-related (ATG) gene expression and protein levels in non-small cell lung cancer (NSCLC) cells.
• To evaluate the impact of TGFβ1 on key autophagy markers, including LC3 lipidation, LC3 puncta formation, and autophagosome-lysosome co-localization.
• To elucidate the role of specific ATG proteins in TGFβ-mediated autophagy in NSCLC.

Main Methods:

• Assessed ATG gene expression and protein levels in response to TGFβ1.
• Utilized LC3 lipidation assays, LC3 puncta imaging, and autophagosome-lysosome co-localization studies.
• Employed pharmacological autophagy modulators (chloroquine, spautin-1, MG132) and validated autophagy flux using a GFP-LC3-RFP-LC3ΔG probe in NSCLC cell lines.
• Investigated the necessity of ATG5 and ATG7 for TGFβ-dependent autophagy.

Main Results:

• TGFβ1, chloroquine, and MG132 increased LC3 lipidation and puncta formation, but not ATG protein levels, suggesting potential limitations in differentiating autophagy activation from lysosomal inhibition with these methods alone.
• Autophagic flux analysis revealed that TGFβ1, MG132, and serum starvation enhanced flux, while chloroquine and spautin-1 inhibited it.
• Demonstrated that ATG5 and ATG7 are essential for TGFβ-dependent autophagy in NSCLC cells.

Conclusions:

• Standard autophagy assessment methods may not reliably distinguish between autophagy activation and lysosomal inhibition.
• TGFβ1 actively modulates autophagic flux in NSCLC cells.
• ATG5 and ATG7 play critical roles in TGFβ-driven autophagy, representing potential targets for therapeutic strategies against NSCLC.